188 related articles for article (PubMed ID: 31633265)
21. Synthesis of 1,4-azaphosphinine nucleosides and evaluation as inhibitors of human cytidine deaminase and APOBEC3A.
Kvach MV; Harjes S; Kurup HM; Jameson GB; Harjes E; Filichev VV
Beilstein J Org Chem; 2024; 20():1088-1098. PubMed ID: 38774272
[TBL] [Abstract][Full Text] [Related]
22. Strand-biased cytosine deamination at the replication fork causes cytosine to thymine mutations in Escherichia coli.
Bhagwat AS; Hao W; Townes JP; Lee H; Tang H; Foster PL
Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2176-81. PubMed ID: 26839411
[TBL] [Abstract][Full Text] [Related]
23. Heat shock proteins stimulate APOBEC-3-mediated cytidine deamination in the hepatitis B virus.
Chen Z; Eggerman TL; Bocharov AV; Baranova IN; Vishnyakova TG; Kurlander R; Patterson AP
J Biol Chem; 2017 Aug; 292(32):13459-13479. PubMed ID: 28637869
[TBL] [Abstract][Full Text] [Related]
24. Crystal structure of APOBEC3A bound to single-stranded DNA reveals structural basis for cytidine deamination and specificity.
Kouno T; Silvas TV; Hilbert BJ; Shandilya SMD; Bohn MF; Kelch BA; Royer WE; Somasundaran M; Kurt Yilmaz N; Matsuo H; Schiffer CA
Nat Commun; 2017 Apr; 8():15024. PubMed ID: 28452355
[TBL] [Abstract][Full Text] [Related]
25. APOBEC3 Host Restriction Factors of HIV-1 Can Change the Template Switching Frequency of Reverse Transcriptase.
Adolph MB; Ara A; Chelico L
J Mol Biol; 2019 Mar; 431(7):1339-1352. PubMed ID: 30797859
[TBL] [Abstract][Full Text] [Related]
26. Catalytic analysis of APOBEC3G involving real-time NMR spectroscopy reveals nucleic acid determinants for deamination.
Kamba K; Nagata T; Katahira M
PLoS One; 2015; 10(4):e0124142. PubMed ID: 25875164
[TBL] [Abstract][Full Text] [Related]
27. Structural Investigations on the Interactions between Cytidine Deaminase Human APOBEC3G and DNA.
Yan X; Lan W; Wang C; Cao C
Chem Asian J; 2019 Jul; 14(13):2235-2241. PubMed ID: 31116511
[TBL] [Abstract][Full Text] [Related]
28. The intrinsic antiretroviral factor APOBEC3B contains two enzymatically active cytidine deaminase domains.
Bogerd HP; Wiegand HL; Doehle BP; Cullen BR
Virology; 2007 Aug; 364(2):486-93. PubMed ID: 17434555
[TBL] [Abstract][Full Text] [Related]
29. Asymmetric Modification of Hepatitis B Virus (HBV) Genomes by an Endogenous Cytidine Deaminase inside HBV Cores Informs a Model of Reverse Transcription.
Nair S; Zlotnick A
J Virol; 2018 May; 92(10):. PubMed ID: 29491156
[TBL] [Abstract][Full Text] [Related]
30. APOBEC3G is a single-stranded DNA cytidine deaminase and functions independently of HIV reverse transcriptase.
Suspène R; Sommer P; Henry M; Ferris S; Guétard D; Pochet S; Chester A; Navaratnam N; Wain-Hobson S; Vartanian JP
Nucleic Acids Res; 2004; 32(8):2421-9. PubMed ID: 15121899
[TBL] [Abstract][Full Text] [Related]
31. APOBEC3G/3A Expression in Human Immunodeficiency Virus Type 1-Infected Individuals Following Initiation of Antiretroviral Therapy Containing Cenicriviroc or Efavirenz.
Covino DA; Purificato C; Catapano L; Galluzzo CM; Gauzzi MC; Vella S; Lefebvre E; Seyedkazemi S; Andreotti M; Fantuzzi L
Front Immunol; 2018; 9():1839. PubMed ID: 30135687
[TBL] [Abstract][Full Text] [Related]
32. Crystal structure of DNA cytidine deaminase ABOBEC3G catalytic deamination domain suggests a binding mode of full-length enzyme to single-stranded DNA.
Lu X; Zhang T; Xu Z; Liu S; Zhao B; Lan W; Wang C; Ding J; Cao C
J Biol Chem; 2015 Feb; 290(7):4010-21. PubMed ID: 25542899
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis B: modern concepts in pathogenesis--APOBEC3 cytidine deaminases as effectors in innate immunity against the hepatitis B virus.
Bonvin M; Greeve J
Curr Opin Infect Dis; 2008 Jun; 21(3):298-303. PubMed ID: 18448976
[TBL] [Abstract][Full Text] [Related]
34. Biochemical Basis of APOBEC3 Deoxycytidine Deaminase Activity on Diverse DNA Substrates.
Adolph MB; Love RP; Chelico L
ACS Infect Dis; 2018 Mar; 4(3):224-238. PubMed ID: 29347817
[TBL] [Abstract][Full Text] [Related]
35. Understanding the regulation of APOBEC3 expression: Current evidence and much to learn.
Covino DA; Gauzzi MC; Fantuzzi L
J Leukoc Biol; 2018 Mar; 103(3):433-444. PubMed ID: 29345375
[TBL] [Abstract][Full Text] [Related]
36. Structure-Guided Design of a Potent and Specific Inhibitor against the Genomic Mutator APOBEC3A.
Serrano JC; von Trentini D; Berríos KN; Barka A; Dmochowski IJ; Kohli RM
ACS Chem Biol; 2022 Dec; 17(12):3379-3388. PubMed ID: 36475588
[TBL] [Abstract][Full Text] [Related]
37. Dimerization regulates both deaminase-dependent and deaminase-independent HIV-1 restriction by APOBEC3G.
Morse M; Huo R; Feng Y; Rouzina I; Chelico L; Williams MC
Nat Commun; 2017 Sep; 8(1):597. PubMed ID: 28928403
[TBL] [Abstract][Full Text] [Related]
38. Efficient deamination of 5-methylcytosines in DNA by human APOBEC3A, but not by AID or APOBEC3G.
Wijesinghe P; Bhagwat AS
Nucleic Acids Res; 2012 Oct; 40(18):9206-17. PubMed ID: 22798497
[TBL] [Abstract][Full Text] [Related]
39. Degradation of the cancer genomic DNA deaminase APOBEC3B by SIV Vif.
Land AM; Wang J; Law EK; Aberle R; Kirmaier A; Krupp A; Johnson WE; Harris RS
Oncotarget; 2015 Nov; 6(37):39969-79. PubMed ID: 26544511
[TBL] [Abstract][Full Text] [Related]
40. Crystal structure of the anti-viral APOBEC3G catalytic domain and functional implications.
Holden LG; Prochnow C; Chang YP; Bransteitter R; Chelico L; Sen U; Stevens RC; Goodman MF; Chen XS
Nature; 2008 Nov; 456(7218):121-4. PubMed ID: 18849968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
